Article Text

Download PDFPDF
Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial
  1. P A Poole-Wilson1,
  2. S J Pocock2,
  3. K A A Fox3,
  4. R A Henderson4,
  5. D J Wheatley5,
  6. D A Chamberlain6,
  7. T R D Shaw7,
  8. T C Clayton2,
  9. for the Randomised Intervention Trial of unstable Angina (RITA) Investigators
  1. 1Department of Cardiac Medicine, National Heart and Lung Institute, Imperial College London, London, UK
  2. 2Medical Statistics Unit, London School of Hygiene & Tropical Medicine, London, UK
  3. 3Cardiovascular Research, Department of Medical and Radiological Sciences, Royal Infirmary, Edinburgh, UK
  4. 4Nottingham City Hospital NHS Trust, Nottingham, UK
  5. 5Department of Cardiac Surgery, Glasgow Royal Infirmary, Glasgow, UK
  6. 6Prehospital Emergency Research Unit, School of Medicine, Cardiff University Woodland Drive, Hove, UK
  7. 7Department of Cardiology, Western General Hospital, Edinburgh, UK
  1. Correspondence to:
    Professor P A Poole-Wilson
    Cardiac Medicine, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK; p.poole-wilson{at}imperial.ac.uk

Abstract

Objective: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time.

Methods: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) patients were randomly assigned to coronary angiography (median 2 days after randomisation) and appropriate intervention (n  =  895) or to a symptom-guided conservative strategy (n  =  915).

Results: In the first week patients in both groups were at highest risk of death, myocardial infarction (MI) or refractory angina (incidence rate 40 times higher than in months 5–12 of follow up). There were 22 MIs and 6 deaths in the intervention group (largely due to procedure-related events, 14 MIs and 3 deaths) versus 17 MIs and 3 deaths in the conservative group. In the rest of the year there were an additional 12 versus 27 MIs, respectively (treatment–time interaction p  =  0.021). Over one year in the intervention group there was a 43% reduction in refractory angina; 22% of patients underwent coronary artery bypass surgery and 35% underwent percutaneous coronary intervention only, which reduced refractory angina but provoked some early MIs; and 43% were still treated medically, mostly because of a favourable initial angiogram.

Conclusion: Any intervention policy needs to recognise the high risk of events in the first week and the substantial minority of patients not needing intervention. Intervention may be best targeted at higher risk patients, as the early hazards of the procedure are then offset by reduced subsequent events.

  • CABG, coronary artery bypass graft
  • FRISC II, Fragmin and Fast Revascularisation during Instability in Coronary artery disease
  • ICTUS, Invasive versus Conservative Treatment in Unstable Coronary Syndromes
  • MI, myocardial infarction
  • PCI, percutaneous coronary intervention
  • RITA 3, Randomised Intervention Trial of unstable Angina 3
  • TACTICS, Treat angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy
  • VANQWISH, Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital
  • acute coronary syndrome
  • coronary angiography
  • myocardial ischaemia
  • percutaneous coronary intervention

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Published Online First 18 April 2006